INTRODUCTION
============

*Francisella* as the single member of *Francisellaceae* family has no intimate phylogenetic relatives to other pathogenic bacteria. There are just some far phylogenetic relationships between *Francisella*, *Legionella*, and *Coxiella burnetti* \[[@r1], [@r2]\].

There are four well-known subspecies belonging to *Francisella tularensis* (*F. tularensis*) including *holarctica* (Type B), *mediasiatica*, *novicida*, and *tularensis* (Type A). *F. tularensis* subsp. *tularensis* is recognized as the most deathful subspecies which encompasses a vast range of virulent factors \[[@r3]-[@r5]\].

The intracellular gram negative bacterium of *F. tularensis* is an invasive pathogenic microorganism which may lead to fatal infectious disease of tularemia in the host with a low infective cell number of 10. The zoonotic infection of tularemia is clinically divided into six forms of Glandular, Oculoglandular, Oropharyngeal, Respiratry, Typhoidal and Ulceroglandular diseases \[[@r5]-[@r10]\].

Respiratory tularemia is recognized as the most severe form of tularemia with a mortality rate up to 30% if not treated; therefore, *F. tularensis* is known as a potential biological weapon and categorized in group A of bacterial pathogenic agents \[[@r1], [@r7], [@r11]-[@r15]\].

Because of the life threatening and severity of respiratory tularemia, the use of a rapid, accurate, and reliable diagnostic technique is an urgent. An accurate diagnosis may lead to a definite and effective treatment. Hence, among different diagnostic methods such as microbiological cultures, serological assays, Polymerase Chain Reactions (PCRs) including real-time PCR, Enterobacterial Repetitive Intergenic Consensus PCR (ERIC-PCR) *etc.* and other routine techniques, the advanced molecular technique of DNA microarray is recommended \[[@r16]-[@r22]\].

DNA microarray technology is an advanced pan-genomic diagnostic technique which is consisted of two main parts including Dry Lab and Wet Lab. The bioinformatic section which covers the dry lab procedures is known as the *in silico* portion of the DNA Microarray technique. So, the probe designing processes construct the dry lab section of the tool. The wet lab of the technique concludes the *in vitro* portion of the technique. The wet lab section is composed of probe printing on a suitable coated surface of a glass slide (by robotic spotter), labeling of target bacterial genome (by fluorescent dyes such as Cy3 and Cy5), hybridization process (manually or automatically) and scanning. Even an ideal performed wet lab section is completely depended on the accuracy of probe designing procedures. An appropriate microarray probe designing guarantees the accuracy of outcomes resulted from DNA microarray technology and reduces the probable biases. Of course, a non-expertized done probe designing predominates the expertized wet lab procedures and gives huge noises, biases and enormous errors in final data. A well done microarray probe designing guarantees a rapid, accurate, sensitive, specific and cost effective diagnostic technique when the number of clinical specimens is high \[[@r16], [@r19], [@r20], [@r23]-[@r28]\].

Therefore, the main goal of the present research is to provide and design best candidates of microarray probes for diagnosing *F. tularensis*.

MATERIAL AND METHODS
====================

As mentioned before, *F. tularensis* involves four subspecies of *holarctica* (Type B), *mediasiatica*, *novicida*, and *tularensis* (Type A). Besides, *F. philomiragia* is another species within the genus. However, there are considerable similarities between species and subspecies \[[@r1], [@r2], [@r29]-[@r31]\].

For this reason, the authors have used GView Server (<https://server.gview.ca>) to show unique sequences in *F. tularensis* subspecies and F.*philomiragia* (Fig. **[1](#F1){ref-type="fig"}**) \[[@r24], [@r25], [@r32], [@r33]\].

Regarding to GView Server application, the "unique genome" was selected for analysis type. Then the .gbk file belonging to *F. tularensis* subsp. *tularensis* FSC198 chromosome complete genome was downloaded from NCBI FTP site in FASTA format (<http://ftp.ncbi.nlm.nih.gov/genomes/Bacteria/>), zipped and uploaded as a reference genome \[[@r24], [@r25], [@r32]-[@r34]\].

Then, the downloaded .fna files belonging to *F. tularensis* subsp. *holarctica* LVS (Type B), *F. tularensis* subsp. *mediasiatica*, *F. tularensis* subsp. *novicida* (*F. novicida* U112), and *F. philomiragia* subsp. *philomiragia* ATCC 25017 from (<https://lfz.corefacility.ca/panseq/analyses/>) were also zipped and uploaded for comparing their genomes with the genome of *F. tularensis* subsp. *tularensis* FSC198 (Fig. **[1](#F1){ref-type="fig"}**). All of the parameters in GView Server were set up as default position of the server \[[@r24], [@r25], [@r32], [@r34], [@r35]\].

For determining and analysing the unique sequences of *F. tularensis* subsp. *tularensis* FSC198 (NC_008245), the PanSeq Server ([http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch&LINK_LOC =blasthome](http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch&LINK_LOC =blasthome)) was used. To perform the analysis throughout the novel region detector, *F. tularensis* subsp. *tularensis* FSC198 (NC_008245) presumed as the selected query and the other aforementioned species and subspecies were determined as selected references. Because of high genomic similarities among *F. tularensis* subspecies, the *F. tularensis* subsp. *tularensis* FSC198 complete genome was compared only with *F. philomiragia* subsp. *philomiragia* ATCC 25017 chromosome complete genome. The related parameters in PanSeq Server were set up according to default choices \[[@r1], [@r2], [@r24], [@r25], [@r29]-[@r31], [@r33]\].

The unique sequences of *F. tularensis* subsp. *tularensis* FSC198 were finally detected and blasted by the BLAST tool which is accessible *via* NCBI ([http://blast.ncbi.nlm.nih.gov/Blast.cgi? PROGRAM=blastn & PAGE_TYPE= BlastSearch& LINK_LOC=blasthome](http://blast.ncbi.nlm.nih.gov/Blast.cgi? PROGRAM=blastn & PAGE_TYPE= BlastSearch& LINK_LOC=blasthome)) \[[@r16], [@r19], [@r24], [@r25], [@r33], [@r34], [@r36], [@r37]\].

The super unique regions identified by BLAST tool were then processed for microarray probe designing. Therefore, the AlleleID 7.7 software was used for designing long oligo microarray probes. The length of probes were selected between 55 and 64 nucleotides. Other parameters regarding AlleleID software were selected in accordance with default forms \[[@r16], [@r24], [@r25], [@r33], [@r34]\].

The designed probes were then evaluated *via* NCBI BLAST tool. The confirmed microarray probes were finally tested by oligoanalyzer 3.1 (<https://eu.idtdna.com/calc/analyzer>) (an online tool) for appropriate structure and suitable physico-chemical characteristics. The related properties were identified *via* hairpin button. Other parameters were presumed as default position. Finally, the proper microarray probes were designed and produced to prepare a diagnostic DNA microarray chip \[[@r16], [@r19], [@r24], [@r33], [@r34], [@r36]\].

RESULTS
=======

The genomic maps relating to each species and subspecies are shown in Fig. (**[1](#F1){ref-type="fig"}**). The figure indicates the comparative pangenomic result obtained from pangenome analysis achieved by GView Server. Each color is pertaining to an individual strain. The colored regions involved similar sequences relating to genomes while the white regions are unique sectors among bacterial cases.

In addition to Gview server, the pan-genomic analyses achieved by PanSeq server. The results revealed unique genomic sectors within the aforementioned species and subspecies genomes including *F. tularensis* subsp. *tularensis* FSC198 (NC_008245), *F. tularensis* subsp. *holarctica* (NC_007880), *F. tularensis* subsp. *mediasiatica* (NC_010677), *F. tularensis* subsp. *novicida* (*F. novicida* U112) (NC_008601), and *F. philomiragia* (NC_010336). These analyses were vital for recognizing the unique regions for each strain.

The utilization of important pangenomic servers like Geview and PanSeq, BLAST tool (NCBI), probe designing soft ware of AlleleID 7.7 was necessary for obtaining 15 probes as the best candidate long oligo DNA microarray probes for detection and identification of *F. tularensis*. The processed and best candidate long oligo DNA microarray probes with high sensitivity and specificity are indicated in Table **[1](#T1){ref-type="table"}**. These suggested probes were appropriate for recognition of *F. tularensis* \[[@r24]\].

DISCUSSION
==========

Tularemia is recognized as a reemerging infectious disease with a high number of outbreaks in different countries. Besides, there are many similarities between respiratory tularemia and other respiratory infectious diseases such as mycobacterial tuberculosis, mycotic and different bacterial pneumonia, lung abscess, lung lymphoma, lung carcinoma, influenza and acute respiratory distress syndrome (ARDS). The general clinical demonstrations relating to pulmonary tularemia are variable from bronchitis, bronchopneumonia and pharyngitis to hilar lymphadenitis and pleuropneumonitis \[[@r6], [@r13], [@r15], [@r38], [@r39]\].

Because of the severity of respiratory tularemia and its fast progression within the host tissues, a rapid, accurate, sensitive, specific, reliable and cost effective diagnostic technique like microarray technology is needed for an appropriate diagnosis and a definite antibiotic therapy \[[@r8], [@r16]-[@r20], [@r23], [@r40]-[@r44]\].

There are different traditional microbiological diagnostic methods including direct microscopic observations of clinical specimens, histological studies, medium culture, serological assays, enzyme linked immuno sorbent assay (ELISA), and imaging. But these techniques are time consuming with low specificity and sensitivity \[[@r6], [@r7], [@r45]\].

PCRs such as nested PCR, ERIC PCR, real-time PCR are suitable diagnostic assays with high accuracy, sensitivity and specificity when the number of samples is low. They also are cost effective; but, they are not accurate, sensitive, specific and cost effective in the cases with huge number of specimens \[[@r16], [@r17], [@r21], [@r24], [@r25], [@r36], [@r41], [@r43], [@r46]\].

Indeed, the microarray technology is used for detection and identification of several microbial DNA sequence targets which are mixed within a clinical specimen \[[@r22], [@r47]\].

The microbial genomics has increased the optimization of diagnostic methods during last decade. The progression of free web databases and next generation sequencing (NGS) technologies such as DNA microarray provide us with a rapid, and reliable diagnostic tool for accurate detection and identification of pathogenic agents in microbiological samples to have definite therapeutic methods \[[@r16], [@r19], [@r20], [@r41]\].

Despite the importance of each procedure of DNA microarray technique, the probe designing performance is a critical and considerable procedure which makes DNA microarray technology a rapid, reiable, accurate, sensitive, specific and flexible diagnostic method. The sequence, calibration and the length of microarray probes directly affect the quality of analytical outcomes \[[@r16], [@r23]-[@r25], [@r33], [@r42], [@r48]\].

DNA microarray technology is an advanced diagnostic tool which enables us to detect and identify the target DNA sequences among hundreds of thousand sequences, genes, and microorganisms. As, the human respiratory tract possesses a complicated microbiome and the pathogenic agents of this tract include bacteria, fungi, parasites and viruses, so DNA microarray technology is a proper and preferred diagnostic tool \[[@r16], [@r20], [@r43], [@r49], [@r50]\].

According to the text above, rapidity and accuracy are two important factors in association with recognition of respiratory tularemia; Because, a rapid and accurate diagnosis may lead to a fast and definite treatment which resulting in improvement and reducing the mortality rate among patients with pulmonary tularemia. Moreover, the possibility of microarray probe designing provides us to have a vast range of probes. This ability makes DNA microarray a flexible, easy, simple, cost effective and useful technique. Moreover, the DNA microarray technique is able to recognize multi-drug resistant microbial strains \[[@r24], [@r26], [@r33]\].

CONCLUSION
==========

Microarray probe designing enables us to choose the best candidates among several choices and to design a microarray chip with local genomic microbial species and strains with high efficacy. An expert of microarray probe designing, reduces the cost of chip upgrading process.
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###### 15 Best candidate microarray probes for detection and identification of *F. tularensis*.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Microorganism**                                                 **Long oligo Microarray Probe**                             **Length**                                    **Location and gene product**
  ----------------------------------------------------------------- ----------------------------------------------------------- --------------------------------------------- -------------------------------
  *F. tularensis*                                                   ATATTCTACTAAAGTCCTACTTCCATCAGCAGGGCACAATTCTTGACCATCAGGTAA   57                                            **115132-115188**\
                                                                                                                                                                              **Hypothetical protein**

  ACGTTACCTGACAATATAGACAGTGACAAAATAGAAGCTAAATACAGTAATGGTGTACTAAGC   63                                                          **118942-119004 molecular chaperone Hsp20**   

  TGTGCTTACAAGGGAAAGGCTATGCTTTATTACCAAAGTCAGACATTATAGACGAAA         57                                                          **1861738-1861794**\                          
                                                                                                                                **Hypothetical protein**                      

  AGAGACATCGTAATTAATAAACATGAAGAAGGTATGACGGAGTTCGAGCTGAGTAAGTTT      60                                                          **3776-3835**\                                
                                                                                                                                **Transposase family protein**                

  AGGGACTTCGATTATATAGTTACCATTGATGTAATATACTGTACCTCCAGCAACAACTGC      60                                                          **10755-10814**\                              
                                                                                                                                **Membrane protein**                          

  CGTCGAAATTACATCAATAGTCGCATTTATCTTAACAGTTCTTATATATCGTGAGCATTGGCT   63                                                          **16750-16812**\                              
                                                                                                                                **Nicotinamide mononucleotide transporter**   

  AGAGTCAGGAGAGATTGAGCCAATATCTTTGCCACTTATACTAATTGTGTAGTTAATAGC      60                                                          **20655-20714**\                              
                                                                                                                                **Chitinase**                                 

  TAGATAATGTGCTTTGGTCAGGTCGGGTTGCTGATAAATCAAATAACGAGGTAAACA         57                                                          **18798-18854**\                              
                                                                                                                                **SAM-dependent methyltransferase**           

  AAGTTAGATGCTTTAGTATTTACAGGAGGTATTGGTGAGAATGCTGCTAATATCCGT         57                                                          **96305-96361**\                              
                                                                                                                                **Acetate kinase**                            

  TACTACTTGGCTGGATCGGTGTTCGCTTGATGAATAAATCAGATGATGGTAATACTCT        57                                                          **1859056-1859113**\                          
                                                                                                                                **Sodium:proton antiporter**                  

  AACATCAGTATCTAATCCACTACCTCGAATCTTACACAAAGCAACATCTATCCCATCT        58                                                          **29176-29233**\                              
                                                                                                                                **Anhydro-N-acetylmuramic acid kinase**       

  AGAACCTCTTAGTCGTATTTACTATTACTTAGCCGTGCCAATTACCAGCAAATCAGTTAAAGA   63                                                          **38292-38354**\                              
                                                                                                                                **Hypothetical protein**                      

  ACAACCATCACCATCCTTATCCGATGTAACTACAAGTTCATGTCCTAGTTCTTCTAA         57                                                          **1873414-1873470**\                          
                                                                                                                                **Formate dehydrogenase**                     

  TTTCATAATAACACCATTTATCGCAGCACCAACAACAAACCCAGCAATAAGTATCGC         57                                                          **51911-51967**\                              
                                                                                                                                **Membrane protein**                          

  TAACACTAGAACCATGCTGTCACTGTGGAAGAACTCCTCCCTGTACTGATACCATAAT        58                                                          **33959-34016**\                              
                                                                                                                                **Pyrimidine reductase**                      
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
